Bradley & Co Private Wealth Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-370
| Closed | -$2.62K | – | 199 |
|
|
2023
Q3 | $2.62K | Hold |
370
| – | – | ﹤0.01% | 150 |
|
|
2023
Q2 | $2.61K | Hold |
370
| – | – | ﹤0.01% | 153 |
|
|
2023
Q1 | $3.09K | Hold |
370
| – | – | ﹤0.01% | 147 |
|
|
2022
Q4 | $4.25K | Hold |
370
| – | – | 0.01% | 141 |
|
|
2022
Q3 | $5K | Hold |
370
| – | – | 0.01% | 141 |
|
|
2022
Q2 | $4K | Hold |
370
| – | – | ﹤0.01% | 152 |
|
|
2022
Q1 | $6K | Hold |
370
| – | – | 0.01% | 133 |
|
|
2021
Q4 | $5K | Hold |
370
| – | – | ﹤0.01% | 138 |
|
|
2021
Q3 | $5K | Hold |
370
| – | – | ﹤0.01% | 144 |
|
|
2021
Q2 | $6K | Hold |
370
| – | – | 0.01% | 149 |
|
|
2021
Q1 | $4K | Buy |
+370
| New | +$4K | ﹤0.01% | 152 |
|